Publication | Closed Access

Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension

Endothelin-a Receptor AntagonistHypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseAntihypertensive TherapyVascular PharmacologyPulmonary HypertensionVascular BiologyPharmacotherapyPublic HealthMedicineClinical EfficacyCardiologyPulmonary Vascular DiseaseAnesthesiology